Valsts: Rumānija
Valoda: angļu
Klimata pārmaiņas: HMA (Heads of Medicines Agencies)
ceftiofur hydrochloride 50 mg/ml
SUPER´S DIANA, S.L.
QJ01DD90
Suspension for injection
Ceftiofur
Pigs Food
2013-02-20
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT DIACEF 50 mg/ml suspension for injection for pigs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION One ml contains: ACTIVE SUBSTANCE: Ceftiofur (hydrochloride) ........................................... 50 mg For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Suspension for injection. Homogeneous and lump-free white-cream colour suspension 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Pigs 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For the treatment of bacterial respiratory disease associated with _Pasteurella multocida, _ _Actinobacillus pleuropneumoniae _and _Streptococcus suis_, sensitive to ceftiofur. 4.3 CONTRAINDICATIONS Do not administer to an animal previously found to be hypersensitive to ceftiofur and other -lactam antibiotics. Do not inject intravenously. Do not use in poultry (including eggs) due to risk of spread of antimicrobial resistance to humans. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES None. 4.5 SPECIAL PRECAUTIONS FOR USE SPECIAL PRECAUTIONS FOR USE IN ANIMALS Inappropriate use of the product may increase the prevalence of bacteria resistance to cephalosporins. Use of the product should be based on susceptibility testing and take into account official and local antimicrobial policies. - This veterinary medicinal product selects for resistant strains such as bacteria carrying extended spectrum beta-lactamases (ESBL) and may constitute a risk to human health if these strains disseminat Izlasiet visu dokumentu